Neuronetics, Inc. (NASDAQ: STIM) recently announced a definitive agreement with Greenbrook TMS Inc. (OTC: GBNHF) to acquire its outstanding common shares in an all-stock transaction. Following the merger’s completion, Greenbrook will be able to improve its existing sites to provide the benefits of NeuroStar to any practice across the country. It will do so using Neuronetics’ innovative NeuroStar platform as well as its education and training expertise. The merger agreement will help Neuronetics strengthen its position in the mental health market. The agreement provides the company with multipl…